JPH0563452B2 - - Google Patents

Info

Publication number
JPH0563452B2
JPH0563452B2 JP58227786A JP22778683A JPH0563452B2 JP H0563452 B2 JPH0563452 B2 JP H0563452B2 JP 58227786 A JP58227786 A JP 58227786A JP 22778683 A JP22778683 A JP 22778683A JP H0563452 B2 JPH0563452 B2 JP H0563452B2
Authority
JP
Japan
Prior art keywords
calcium
composition
yeast
amount
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58227786A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59110624A (ja
Inventor
Seruji Guranbeeru Joruji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPS59110624A publication Critical patent/JPS59110624A/ja
Publication of JPH0563452B2 publication Critical patent/JPH0563452B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP58227786A 1982-12-01 1983-12-01 有機塩及び／又は無機塩と微生物との組合わせ Granted JPS59110624A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8220124A FR2536996B1 (fr) 1982-12-01 1982-12-01 Association permettant d'ameliorer l'absorption de divers cations par l'organisme
FR8220124 1983-12-01

Publications (2)

Publication Number Publication Date
JPS59110624A JPS59110624A (ja) 1984-06-26
JPH0563452B2 true JPH0563452B2 (en]) 1993-09-10

Family

ID=9279686

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58227786A Granted JPS59110624A (ja) 1982-12-01 1983-12-01 有機塩及び／又は無機塩と微生物との組合わせ

Country Status (8)

Country Link
US (1) US4591503A (en])
EP (1) EP0113608B1 (en])
JP (1) JPS59110624A (en])
AT (1) ATE52696T1 (en])
CA (1) CA1221630A (en])
DE (2) DE3381554D1 (en])
FR (1) FR2536996B1 (en])
NL (1) NL930117I1 (en])

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2536996B1 (fr) * 1982-12-01 1985-09-27 Grimberg Georges Association permettant d'ameliorer l'absorption de divers cations par l'organisme
CH666184A5 (it) * 1985-08-06 1988-07-15 Seuref Ag Composizione farmaceutica orale a base di ubichinoni.
FR2600890B1 (fr) * 1986-07-03 1990-02-23 Moreau Pierre Nouvelles compositions riches en oligoelements et leurs procedes de fabrication.
ES2032844T3 (es) * 1987-07-09 1993-03-01 Pierre Moreau Nuevos composiciones ricas en oligoelementos y sus procedimientos de fabricacion.
FR2679775B1 (fr) * 1991-08-01 1994-11-18 Grimbert Georges Medicament a base de derives soufres neutralises.
FR2702655B1 (fr) * 1993-03-18 1995-06-16 Grimberg Georges Serge Composition therapeutique nouvelle ayant un effet immunostimulant.
NZ501933A (en) * 1997-07-05 2001-08-31 Nestle Sa Use of lactobacilli in enteral nutritional compositions for improved mineral absorption
JP2004292382A (ja) * 2003-03-27 2004-10-21 Kirin Brewery Co Ltd ミネラル吸収促進剤及び骨粗鬆症用予防及び／又は改善剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA503705A (en) * 1954-06-15 J. Miller John Dentifrice containing urea and urease
GB1440217A (en) * 1973-09-26 1976-06-23 Ici Ltd Compositions
US3928567A (en) * 1974-08-26 1975-12-23 Ariel A Andersen Dietary supplement
US4035479A (en) * 1975-11-14 1977-07-12 Celanese Corporation Delayed and sustained urea release compositions
JPS5818068B2 (ja) * 1977-08-29 1983-04-11 出光興産株式会社 風味と分散性が改良された酵母菌体の製造方法
FR2536996B1 (fr) * 1982-12-01 1985-09-27 Grimberg Georges Association permettant d'ameliorer l'absorption de divers cations par l'organisme

Also Published As

Publication number Publication date
NL930117I1 (nl) 1993-11-01
JPS59110624A (ja) 1984-06-26
FR2536996A1 (fr) 1984-06-08
FR2536996B1 (fr) 1985-09-27
ATE52696T1 (de) 1990-06-15
EP0113608A1 (fr) 1984-07-18
CA1221630A (en) 1987-05-12
DE3381554D1 (de) 1990-06-21
EP0113608B1 (fr) 1990-05-16
DE113608T1 (de) 1985-01-17
US4591503A (en) 1986-05-27

Similar Documents

Publication Publication Date Title
Leavell et al. Hydroxyurea: A new treatment for psoriasis
CN1083264C (zh) 含有鸦片样拮抗剂和钙盐的药物组合物及其在治疗内啡肽介导的疾病中的应用
AU776318B2 (en) Topical zinc compositions and methods of use
US4590213A (en) Anti-anxiety method
TWI331920B (en) Unit dosage form for relieving or treating constipation in human patients
JPH0563452B2 (en])
JPH01151515A (ja) 骨粗鬆症および関連障害の治療法
JP3622985B2 (ja) マグネシウム吸収を高め、アテローム性動脈硬化症を防ぐ方法
WO1999017612A1 (en) Serotonin containing formulation for oral administration and method of use
JPH06263644A (ja) リチウム治療剤
NO309965B1 (no) Oralt farmasøytisk antihostepreparat
KR100304312B1 (ko) 아연이보충된전립선추출물
JPH0340010B2 (en])
MITTLEMAN et al. Thyrocalcitonin activity in hypercalcemia produced by calcium salts, parathyroid hormone and vitamin D
CA2555328C (en) Composition, comprising l-serine, l-isoleucine, folic acid and trace elements, for treating psoriasis
AU651824B2 (en) Pharmaceutical composition
Hanley et al. Danger of withdrawal of vasodilator therapy in patients with chronic heart-failure
Modell Drugs in Current Use 1958
EP0372676A1 (en) Therapeutic preparation and method
JPH0518811B2 (en])
JP2007533609A (ja) 哺乳動物におけるマグネシウム摂取の強化
HK1205951A1 (en) Use of 7-t-butoxyiminomethylcamptothecin for the prepartion of a medicament for the treatment of uterine neoplasms
DE3247514C2 (en])
US20100226968A1 (en) Topical agent for muscle treatment
AU629520B2 (en) A medicament